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Background: Synthetic double-stranded RNA poly(I:C) is a useful immune adjuvant and exhibits direct antitumor
effects against several types of cancers. In this study, we elucidated the mechanisms underlying the effects induced
in poly(I:C)-transfected human renal cell carcinoma (RCC) cells.
Results: In contrast to the lack of an effect of adding poly(I:C), poly(I:C) transfection drastically decreased RCC cell
viability. Poly(I:C) transfection induced reactive oxygen species (ROS)-dependent apoptosis in RCC cells and decreased
the mitochondrial membrane potential (ΔΨm). Treatment with N-acetyl-L-cysteine (NAC), a ROS scavenger, suppressed
apoptosis and restored the ΔΨm. Although the levels of phosphorylated γH2A.X, an indicator of DNA damage,
increased in poly(I:C)-transfected RCC cells, NAC treatment decreased their levels, suggesting ROS-mediated DNA
damage. Furthermore, poly(I:C) transfection increased the levels of phosphorylated p53, NOXA, and tBid. Immunoblots
and assays with a panel of caspase inhibitors revealed that poly(I:C) transfection-induced apoptosis was dependent on
caspase-8 and −9, as well as caspase-2. Alternatively, poly(I:C) transfection increased mRNA expression of interferon
(IFN)-β, and treatment with IFN-β suppressed growth of RCC cells without apoptosis. In addition, cyclinD1 and c-Myc
expression decreased in poly(I:C)-transfected RCC cells. Moreover, RNA interference experiments revealed that poly(I:C)
transfection exerted apoptotic effects on RCC cells through innate adjuvant receptors and the 2-5A system, the latter of
which induces apoptosis in virus-infected cells.
Conclusions: These results suggest that poly(I:C) transfection induced two types of effects against RCC cells such as
apoptosis, as a result of ROS-mediated DNA damage, and IFN-β-mediated growth arrest, both of which were exerted
via innate adjuvant receptors and the 2-5A system.
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Immune adjuvant receptors, including Toll-like receptors
(TLRs), play a crucial role in initiating and activating
innate and adaptive immune responses [1]. Therefore, sev-
eral TLR ligands have been utilized in anticancer vaccines
as immune adjuvants with the expectation of augmenting* Correspondence: haramamo@med.shimane-u.ac.jp
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Intriguingly, some types of cancer cells express TLRs, and
TLR ligands provide pro-survival or pro-apoptotic signals
to cancer cells [3]. Lipopolysaccharide, a TLR4 ligand, pro-
vides pro-survival signals to cancer cells, thereby inducing
therapy resistance [4,5], whereas a synthetic double-
stranded RNA (dsRNA) poly(I:C), a ligand for membrane-
bound TLR3, shows direct antitumor effects on a variety
of cancers [6-8]. Additionally, transfecting poly(I:C) into
human melanoma cells induces apoptosis via melanomatral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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poly(I:C) receptor [9,10]. We have also reported that poly
(I:C) transfection exhibits apoptotic effects against human
breast cancer cells, whereas recovery of their viability
by selective MDA5 knockdown is only partial [11]. The
mechanism by which apoptosis is induced and the iden-
tities of receptors and/or mechanisms other than MDA5
that participate in the effects in poly(I:C)-transfected
cancer cells have not been fully elucidated.
Apoptosis is triggered mainly through the extrinsic or in-
trinsic caspase-dependent pathways, and caspase-8 and −9,
respectively, play central roles in these pathways [12]. Acti-
vation of caspase-8 transforms Bid to tBid, thereby promot-
ing mitochondrial-mediated caspase-9-dependent apoptosis
[13]. When cancer cells are exposed to anticancer drugs or
radiation, changes in pro-apoptosis or anti-apoptotic mole-
cules occur on the mitochondrial membrane, leading to
activation of caspase-9 [12]. Alternatively, reactive oxygen
species (ROS) induce intrinsic apoptosis by triggering DNA
damage [14]. Notably, caspase-2 has been suggested to par-
ticipate in ROS-mediated cellular apoptosis [15], but the
precise roles of this “orphan” caspase in cancer cell apop-
tosis have not been fully explained [16].
Cellular apoptosis after viral infection is an antiviral
mechanism that eliminates infected cells and prevents virus
from spreading. Several receptors and mechanisms are
involved in initiating cell death in response to viral infection.
The 2-5A system is one of them and is composed of
the 2′,5′ oligoadenylate synthetase (2-5OAS) and 2-5A-
dependent RNase (RNaseL), both of which are enzymes
that play crucial roles in antiviral defense mechanisms [17].
2-5OAS is activated by dsRNA, an intermediate agent in the
virus replication life cycle, to produce 2-5A (2′,5′ oligoA),
thereby activating RNaseL [18]. Activation of the 2-5A sys-
tem induces degradation of ribosomal RNAs and apoptosis
in mammalian cells [19]. However, whether the 2-5A system
is involved in the antitumor effects induced in poly(I:C)-
transfected human cancer cells has not been determined.
In the present study, we elucidated the underlying
mechanisms of the drastic effects of poly(I:C) trans-
fection on human renal cell carcinoma (RCC) cells. Our
results suggest that poly(I:C) transfection induces two
types of effects against RCC cells: apoptosis, as a result
of ROS-mediated DNA damage, and interferon (IFN)-
β-mediated suppression of cell growth. Additionally, be-
sides caspase-8 and −9, caspase-2 played important roles
in the effects. Furthermore, the effects induced in poly
(I:C)-transfected RCC cells were mediated not only by
innate adjuvant receptors but also by the 2-5A system.
Results
Apoptosis in RCC cells after poly(I:C) transfection
We first examined the effects induced when poly(I:C) was
added or transfected into the two RCC lines (Figure 1a).Although adding poly(I:C) showed no definite effect on
cell viability, poly(I:C) transfection drastically decreased
viability in a dose-dependent manner. SKRC-44 cells were
more susceptible to poly(I:C) transfection than that of
SKRC-1 cells. Figure 1b shows the morphological changes.
Although adding poly(I:C) induced no change in these cell
lines, poly(I:C) transfection induced cell death, as observed
by the non-adherent and shrunken cells. Flow cytometry
after Annexin V/propidium iodide (PI) staining revealed
that poly(I:C) transfection clearly increased the percent-
ages of Annexin V+ cells in both SKRC-1 and SKRC-44
cells compared with those in the other groups (Figure 1c).
ROS generation and decreased mitochondrial membrane
potential (ΔΨm) in poly(I:C)-transfected RCC cells
As ROS are known to be involved in intrinsic apoptosis
[20], we next determined whether poly(I:C) transfection
triggered the generation of ROS, whose levels were evaluated
using 5-(and-6)-carboxy-2′, 7′-dichlorohydrofluorescein
diacetate (carboxy-H2DCFDA), a specific ROS-detecting
fluorescent dye. As a result, staining intensity of carboxy-
H2DCFDA increased in both cell lines after poly(I:C)
transfection, and this increase was inhibited by adding the
ROS scavenger N-acetyl-L-cysteine (NAC) (Figure 2a).
The NAC treatment apparently decreased the percentages
of Annexin V+ cells in poly(I:C)-transfected SKRC-1 and
SKRC-44 cells (Figure 2b), indicating that ROS comprise a
key mediator of apoptosis after poly(I:C) transfection.
We next examined the level of ΔΨm in these cells be-
cause its level is reversely associated with the intrinsic
apoptotic pathway [21]. We examined ΔΨm levels using
the cyanine dye DiOC2(3) and found that the percent-
ages of cells with a high ΔΨm decreased by poly(I:C)
transfection; these decreased percentages were partially
restored by NAC treatment (Figure 2c). We further in-
vestigated the relationship between ΔΨm level and
Annexin V-staining. As shown in Figure 2d, poly(I:C)
transfection increased Annexin V+ RCC cells with a low
ΔΨm, and the NAC treatment conversely decreased
such cells but increased Annexin V− RCC cells with a
high ΔΨm. These results indicate that poly(I:C) transfec-
tion induced ROS generation and thereby induced apop-
tosis in RCC cells in association with decreased ΔΨm.
ROS-mediated DNA damage in poly(I:C)-transfected RCC cells
ROS induce DNA damage, and phosphorylation of his-
tone H2A.X (γH2A.X) (Ser 139) is an indicator of DNA
double-strand breaks. Therefore, we next determined
whether DNA damage was induced in poly(I:C)-trans-
fected RCC cells in a ROS-dependent manner. Figure 3a
shows that poly(I:C) transfection increased phosphoryl-
ation of γH2A.X (Ser 139) in both cell lines, and that
adding of NAC alleviated its expression. Similar results





















































Figure 1 Poly(I:C) transfection can induce apoptosis in RCC cells. (a) RCC cells were cultured with poly(I:C) (white squares) or transfected
with poly(I:C) (black circles) at the indicated doses. Cell viability was determined after 24 h using the WST-8 assay. Similar results were obtained
from three independent experiments. (b) RCC cells were cultured or transfected with poly(I:C) at a dose of 1000 ng/ml for SKRC-1 cells and
500 ng/ml for SKRC-44 cells. Morphological changes were observed microscopically after 24 h. Magnification, ×40. Similar results were obtained
from two independent experiments. (c) RCC cells were cultured or transfected with poly(I:C) (500 ng/ml for SKRC-1 and 50 ng/ml for SKRC-44).
These cells were stained after 24 h with FITC-conjugated Annexin V and PI, and then analyzed by flow cytometry. Numbers represent the
percentages of each subset. Similar results were obtained from five independent experiments. pIC, poly(I:C); pIC-TF, poly(I:C) transfection.
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age in poly(I:C)-transfected RCC cells.
DNA damage induces p53 activation, which can ultim-
ately lead to apoptosis [12,20]. Therefore, we examined
the levels of total and phosphorylated p53, as well as
NOXA and Puma (p53 target molecules) in poly(I:C)-
transfected RCC cells. Although p53 protein levels de-
creased 12 or 24 h after poly(I:C) transfection, phos-
phorylated p53 increased transiently in both cell lines
from 2 to 12 h after poly(I:C) transfection, but decreased
thereafter (Figure 3c), likely due to degradation of total
p53. Although NOXA expression increased shortly after
p53 activation, Puma expression began to decrease 12 h
after poly(I:C) transfection, exhibiting similar kinetics to
those of total p53. Additionally, tBid expression began to
increase 4 or 12 h after poly(I:C) transfection. These re-
sults indicate that poly(I:C) transfection initially trig-
gered p53 activation in conjunction with NOXA, but
degraded p53 thereafter. Furthermore, poly(I:C) trans-
fection caused the conversion of Bid into tBid, leading to
caspase-8 activation in poly(I:C)-transfected RCC cells.
RNA interference was then performed to examine the
role(s) of p53 in poly(I:C) transfection-induced apop-
tosis. Transfection of p53 siRNA decreased p53 protein
expression in both cell lines (Figure 3d). Additionally,
p53 knockdown decreased apoptosis in SKRC-44 cells,but not in SKRC-1 cells (Figure 3e). Moreover, the ef-
fects of p53 knockdown on p53 target molecules were
also examined (Figure 3f ). Although p53 knockdown
increased NOXA expression slightly in poly(I:C)-trans-
fected SKRC-1 cells, its expression was abolished in poly
(I:C)-transfected SKRC-44 cells. Alternatively, p53 knock-
down appeared to promote a decrease in Puma expression
in poly(I:C)-transfected SKRC-1 cells, whereas no appar-
ent change in Puma expression was observed in poly(I:C)-
transfected SKRC-44 cells. These results indicate that
apoptosis and NOXA expression are dependent on p53
activation after poly(I:C) transfection in SKRC-44 cells,
but not in SKRC-1 cells.
Caspase-dependent apoptosis in RCC cells after poly(I:C)
transfection
Because caspases play a central role in apoptosis, we ex-
amined activation of caspases. Poly(I:C) transfection in-
duced cleaved forms of caspase-3, −8, −9, −2, and poly
(ADP-ribose) polymerase (PARP), a caspase substrate, in
these cell lines (Figure 4a). We included caspase-2 be-
cause this caspase has been suggested to be involved in
ROS-mediated apoptosis [15]. As shown in Figure 4b,
adding of z-VAD-fmk, a pan-caspase inhibitor, appar-
ently inhibited the increase in the percentages of
Annexin V+ cells in poly(I:C)-transfected RCC cells.
Figure 2 ROS generation and decreased ΔΨm in poly(I:C)-transfected RCC cells. (a) RCC cells were transfected with poly(I:C) (SKRC-1,
500 ng/ml; SKRC-44, 50 ng/ml) and cultured for 24 h in the presence or absence of NAC (10 mM). Treated cells were stained with carboxy-H2DCFDA.
Numbers represent the mean fluorescence intensity (MFI) of cells in each subset. Similar results were obtained from three independent experiments.
(b) Cells were then stained with Annexin V-FITC and PI and analyzed by flow cytometry. Numbers represent the percentages of cells in each subset.
(c) RCC cells were transfected with poly(I:C) (SKRC-1, 1,000 ng/ml; SKRC-44, 500 ng/ml) and cultured for 24 h in the presence or absence of NAC
(10 mM). Similar results were obtained from three independent experiments. RCC cells were then examined for ΔΨm levels by flow cytometry using
Alexa Fluor 488-conjugated MitoProbe™ DiOC2(3) (8 nM). Numbers represent the percentages of positive cells with ΔΨmhigh. Similar results were
obtained from three independent experiments. (d) RCC cells were then stained with Alexa Fluor 488-conjugated DiOC2(3) (8 nM) and Annexin
V-APC and analyzed by flow cytometry. Numbers represent the percentage of positive cells in each subset. Similar results were obtained from two
independent experiments. pIC-TF, poly(I:C) transfection.
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caspase-8, −9, or −2 also inhibited apoptosis in poly(I:C)-
transfected RCC cells. To examine the influence ofcaspase-2 on poly(I:C) transfection-induced apoptosis
and activation of other caspases, caspase-2 was knocked
down selectively using caspase-2 siRNA (Figure 4c), which
Figure 3 DNA damage and p53 activation in poly(I:C)-transfected RCC cells. SKRC-1 and SKRC-44 cells were transfected with poly(I:C)
(SKRC-1, 1,000 ng/ml; SKRC-44, 500 ng/ml) and cultured for 24 h in the presence or absence of NAC (10 mM). (a) The levels of phosphorylated
γH2AX (Ser 139) in untreated controls (gray) and poly(I:C)-transfected cells (bold line) were examined by flow cytometry. Numbers represent the
mean fluorescence intensities (MFI) of poly(I:C)-transfected cells. Similar results were obtained from three independent experiments. (b) The level
of phosphorylated γH2AX (Ser 139) was examined by immunoblotting. NAC (10 mM) was added 6 h after poly(I:C) transfection. β-actin was used
as a positive control. Similar results were obtained from two independent experiments. (c) Kinetic levels of total p53, phosphorylated p53 (Ser 15),
NOXA, Puma, Bid, and tBid were examined by immunoblotting. β-actin was used as a control. Similar results were obtained from two independent
experiments. (d) P53 protein expression was examined by immunoblotting 3 days after transfection with control siRNA or p53 siRNA. α-tubulin was
used as a control. (e) RCC cells, which were pre-transfected with the indicated siRNAs 3 days prior, were transfected additionally with poly(I:C). The
percentage of Annexin V+ cells were then determined by flow cytometry after 24 h. **p < 0.01. Similar results were obtained from two independent
experiments. (f) Kinetic levels of total p53, NOXA and Puma were examined by immunoblotting. β-actin was used as a control. Similar results were
obtained from two independent experiments. pIC-TF, poly(I:C) transfection.
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file 1: Figure S1), as well as caspase-3, −8, and −9 activa-
tion in poly(I:C)-transfected RCC cells (Figure 4e). These
results indicate that caspase-8 and −9, as well as caspase-
2, are involved in apoptosis in poly(I:C)-transfected RCC
cells, and that caspase-2 influences the activation of
capase-8 and −9.
IFN-β-mediated growth arrest of poly(I:C)-transfected RCC
cells
We next tested the possibility that poly(I:C) transfection
triggers IFN-β, thereby causing growth arrest, since poly
(I:C) induces IFN-β production [22] and IFN-β has the
potential to induce growth arrest in RCC cells [23].
Real-time PCR revealed that poly(I:C) transfection in-
creased IFN-β mRNA expression strongly in both cell
lines (Figure 5a). Treatment with recombinant IFN-β de-
creased viability in both cell lines, but no apparent apop-
tosis was observed (Figure 5b, c). We next examined theproliferation capacity of poly(I:C)-transfected RCC cells.
As shown in Figure 5d, the proportion of bromodeox-
yuridine (BrdU)+ S-phase cells was decreased in poly(I:C)-
transfected RCC cells but increased in the apoptotic
sub-G1 fraction. We also examined the effect of recom-
binant IFN-β on the cell cycle and determined that
IFN-β similarly decreased S-phase cells in both cell lines
(Addditional file 2: Figure S2). The expression levels of cell
cycle-related molecules were examined subsequently,
which revealed that poly(I:C) transfection decreased pro-
tein expression of cyclinD1 and c-Myc in both cell lines
(Figure 5e). Although p21 expression transiently increased
4 h after poly(I:C) transfection in SKRC-1 cells, its expres-
sion decreased rapidly in SKRC-44 cells after poly(I:C)
transfection. Taken together, these data suggest that IFN-β
mediates cell growth arrest, decreases expression of
cyclinD1 and c-Myc, and that both molecules play a role
in decreasing the cell viability of poly(I:C)-transfected
RCC cells.
Figure 4 Caspase-dependent apoptosis in poly(I:C)-transfected RCC cell lines. (a) Two RCC lines were cultured or transfected with poly(I:C)
(SKRC-1, 500 ng/ml; SKRC-44, 50 ng/ml). After 24 h, cleaved forms of a panel of caspases and PARP were evaluated by immunoblotting. β-actin
was used as a control. Similar results were obtained from two independent experiments. (b) RCC lines were cultured or transfected with poly(I:C)
(SKRC-1 and SKRC-44, 500 ng/ml) in the presence of the indicated caspase inhibitors (20 μM). The percentage of Annexin V+ cells was determined
by flow cytometry. Results are presented as the means ± standard deviations of three wells. **p < 0.01 compared with poly(I:C) transfection alone.
Similar results were obtained from two independent experiments. PanCi, pan-caspase inhibitor; C8i, caspase-8 inhibitor; C9i, caspase-9 inhibitor;
C2i, caspase-2 inhibitor. (c) Caspase-2 protein expression was examined by immunoblotting 3 days after transfection with control siRNA or
caspase-2 siRNA. α-tubulin was used as a control. (d) RCC cells, which were pre-transfected with the indicated siRNAs 3 days prior, were
transfected additionally with poly(I:C) (SKRC-1, 1,000 ng/ml; SKRC-44, 500 ng/ml). The percentage of Annexin V+ cells was determined by flow
cytometry after 24 h. Results are presented as the means ± standard deviations of three wells. **p < 0.01. Similar results were obtained from
two independent experiments. (e) After poly(I:C) transfection (SKRC-1, 1,000 ng/ml; SKRC-44, 500 ng/ml), the expression of caspases was
evaluated by immunoblotting. β-tubulin was used as a control. Similar results were obtained from two independent experiments. pIC-TF,
poly(I:C) transfection.
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effects of poly(I:C) transfection in RCC cells
Transfection of poly(I:C) into human melanoma cells
can induce cell death via the cytoplasmic poly(I:C) re-
ceptor MDA5 [9,10]. We have also reported that poly(I:C)
transfection exhibits antitumor effects in human breast
cancer cells [11], but selective knockdown of MDA5
only partially recovers cell viability, suggesting that
other systems are involved. Therefore, we next deter-
mined whether other innate adjuvant receptors and
mechanisms might participate in the effects in poly(I:C)-
transfected RCC cells. Selective knockdown of three
innate adjuvant receptors, retinoic acid-inducible gen
(RIG)-I, MDA5, and TLR3, was confirmed by immuno-
blotting (Figure 6a). Selective knockdown of RIG-I orMDA5 slightly but significantly restored viability of
poly(I:C)-transfected SKRC-1 cells, and selective knock-
down of RIG-I restored viability of poly(I:C)-transfected
SKRC-44 cells (Figure 6b). Additionally, selective knock-
down of TLR3 slightly restored viability of poly(I:C)-
transfected SKRC-44 cells. In addition, we examined
the effect of selective knockdown of interferon regula-
tory transcription factor (IRF)-3 on antitumor effects
in poly(I:C)-transfected RCC cells, as IRF-3 is involved
with the signaling pathways of these three adjuvant
receptors. The result showed that selective knockdown
of IRF-3 significantly restored cell viabilities (Figure 6c, d)
and decreased Annexin V+ apoptotic cells (Figure 6e)
in both cell lines. Recovery of apoptotic cells by the se-
lective knockdown of IRF-3 after poly(I:C) transfection
Figure 5 Effects of IFN-β on RCC growth. (a) Twenty-four hours after poly(I:C) transfection, cells were harvested and real-time PCR was
performed to examine IFN-α and IFN-β mRNA expression. Relative mRNA levels are shown relative to those of β-actin. **p < 0.01. (b) RCC lines
were co-cultured with human IFN-β, and cell viability was determined using the WST-8 assay after 24 h. **p < 0.01. (c) Similarly, after culturing
with human IFN-β (1,000 U/ml), an apoptosis assay was performed using Annexin V and PI staining. Numbers represent the percentages of each
subset. Similar results were obtained from three independent experiments. (d) Both cell lines were cultured or transfected with poly(I:C) (SKRC-1,
100 ng/ml; SKRC-44, 50 ng/ml) for 48 h. Cells were then cultured with BrdU (10 μM) during the last 90 min for SKRC-1 and 6 h for SKRC-44.
After staining with FITC-conjugated anti-BrdU and 7-AAD, cells were analyzed by flow cytometry. Numbers represent the percentages for each
cell cycle phase. Similar results were obtained from two independent experiments. (e) Levels of cyclinD1, c-Myc and p21 were examined by
immunoblotting kinetically after poly(I:C) transfection. β-actin was used as a control. Similar results were obtained from two independent
experiments. pIC-TF, poly(I:C) transfection.
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44 cells.
Partial restoration of cell viability and apoptosis of
poly(I:C)-transfected RCC cells by selective IRF-3 knock-
down led us to search for an alternative mechanism.
dsRNA activates 2-5OAS to produce 2-5A, thereby acti-
vating RNaseL [18]; this 2-5A system degrades viral
RNA and induces apoptosis in virus-infected cells [19].
Therefore, we examined whether the 2-5A system par-
ticipates in the effects observed after poly(I:C) transfec-
tion in RCC cells. As shown in Figure 7a, rRNA was
cleaved in poly(I:C)-transfected RCC cells, suggesting
that RNaseL was activated in RCC cells following poly(I:C)
transfection. Selective knockdown of RNaseL was con-
firmed by immunoblotting (Figure 7b). Knockdown of
RNaseL significantly restored cell viability and decreased
Annexin V+ apoptotic cells in both cell lines (Figure 7c, d).Taken together, these results suggest that both innate adju-
vant receptors and the 2-5A system participate in the poly
(I:C) transfection-induced effects in RCC cell lines.
Discussion
In this study, we revealed that poly(I:C) transfection
induced apoptosis in human RCC cells. Caspases can
be divided into two groups: initiator caspases, including
caspase-8 and −9, and effector caspases, including
caspase-3 and −7 [24]. Caspase-8 and −9 are mainly re-
sponsible for extrinsic and intrinsic caspase-dependent
apoptosis, respectively [25]. In contrast, caspase-2 is
unique in that it has features of both initiator and
effector caspases [26], but the roles of caspase-2 in apop-
tosis remain largely unknown. In this study, we showed
that adding a caspase-2 inhibitor diminished apoptosis
in poly(I:C)-transfected RCC cells, and that selective
Figure 6 Participation of innate adjuvant receptors in antitumor effects of poly(I:C) transfected RCC cells. (a) RCC cells were transfected
with RIG-1, MDA5, TLR3, or control siRNA, and selective knockdown was confirmed by immunoblot assay after 72 h. β-Actin was used as the
control. (b) RCC cells, which were pre-transfected with the indicated siRNA 72 h before, were additionally transfected with poly(I:C) (125 ng/ml
for SKRC-1 and 62.5 ng/ml for SKRC-44). Cell viability was determined by the WST-8 assay after 24 h. Similar results were obtained from two
independent experiments. (c) The RCC cells were transfected with either IRF-3 or control siRNA, or selective knockdown was confirmed after 72 h
by immunoblot assay. β-Actin was used as the control. (d) RCC cells, which were pre-transfected with the indicated siRNA 72 h before, were
additionally transfected with poly(I:C) (250 ng/ml for SKRC-1 and 31.3 ng/ml for SKRC-44). Cell viability was determined by the WST-8 assay after
24 h. Similar results were obtained from two independent experiments. (e) RCC cells, which were pre-transfected with the indicated siRNA 72 h
before, were additionally transfected with poly(I:C) (1000 ng/ml for SKRC-1 and 500 ng/ml for SKRC-44). The percentages of apoptotic cells were
determined by flow cytometry after 24 h. Similar results were obtained from two independent experiments. pIC-TF, poly(I:C) transfection.
*P < 0.05, **P < 0.01.
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vation of caspase-3, −8, and −9 in poly(I:C)-transfected
RCC cells. These results suggest that caspase-2 plays
crucial roles in apoptosis of poly(I:C)-transfected RCC
cells via an effect on caspase-8 and −9. Alternatively, we
showed that caspase-8 was activated in poly(I:C)-trans-
fected RCC cells. Similarly, a previous report showed that
both mitochondrial and caspase-8-dependent pathways
are implicated in poly(I:C)-induced apoptosis in melan-
oma cells [27]. We showed that poly(I:C) transfection in-
duced cleavage of Bid to its active form tBid (Figure 3c).
Bid activation occurs through cleavage by caspase-8,
which generates the truncated form, tBid [13]. As acti-
vation of caspase-8 is generally triggered by extrinsic
death signals, a question remains as to how caspase-8
was activated in poly(I:C)-transfected RCC cells. Note
that activation of caspase-2 has been reported to acti-
vate caspase-8, and sequential activation of caspase-2
and −8 is essential for saikosaponin a-induced apoptosis
in human colon cancer cells [28,29]. These findings suggestthat activation of caspase-8 in poly(I:C)-transfected RCC
cells resulted from activation of caspase-2, and that conver-
sion of Bid to tBid via activation of caspase-2 or −8 con-
tributed to stimulate mitochondria-mediated activation of
caspase-9. Caspase-2 seemed to form a signaling link be-
tween the extrinsic apoptotic and intrinsic mitochondrial-
based apoptotic pathways.
As described above, the extrinsic and intrinsic path-
ways converge at the mitochondrial level and trigger
mitochondrial membrane permeabilization [21,30]. In-
trinsic apoptosis is mediated through a decrease in the
ΔΨm, thereby resulting in the release of cytochrome c
and activation of caspase-9. In this study, we tested the
possibility that ROS were involved in this process be-
cause ROS are recognized as a central mediator in de-
ciding cell fate [31]. Mitochondrial functions depend on
the maintenance of ΔΨm, and loss of this potential leads
to apoptosis [32]. In addition, mitochondrial production
of ROS also appears to play a role in cell death [33]. In
this study, we demonstrated that ROS increased in poly
Figure 7 Participation of the 2-5A system in the poly(I:C) transfection-induced antitumor effect. (a) One day after poly(I:C) transfection
(500 ng/ml), total RNA was extracted, and 4 μg total RNA from each sample was denatured and analyzed by electrophoresis using 1%
agarose-formaldehyde gels, ethidium bromide, and UV light. Similar results were obtained from two independent experiments. M, marker.
(b) RCC cells were then transfected with either RNaseL or control siRNA. After 72 h, selective knockdown was confirmed by immunoblotting.
α-tubulin was used as a control. (c) RCC cells, which were pre-transfected with the indicated siRNAs 72 h prior, were transfected additionally
with poly(I:C) (SKRC-1, 250 ng/ml; SKRC-44, 31.3 ng/ml). Cell viability was determined using a WST-8 assay after 24 h. Similar results were
obtained from three independent experiments. (d) RCC cells, which were pre-transfected with the indicated siRNA 72 h prior, were transfected
additionally with poly(I:C) (SKRC-1, 500 ng/ml; SKRC-44, 50 ng/ml). The proportion of apoptotic cells was determined by flow cytometry after
24 h. Similar results were obtained from three independent experiments. pIC-TF, poly(I:C) transfection. *p < 0.05, **p < 0.01.
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enger, inhibited apoptosis in these cells. In addition,
NAC restored the decreased ΔΨm, and apoptosis and
the level of the ΔΨm were conversely correlated in poly
(I:C)-transfected RCC cells (Figure 2d). Together, these
findings indicate that poly(I:C) transfection induces ROS
first and subsequently decreases the ΔΨm level, result-
ing in activation of caspase-9 and apoptosis.
Poly(I:C) transfection increased γH2A.X phosphoryl-
ation (Ser 139) in RCC cells (Figure 3a, b). Notably, inhib-
ition of ROS with NAC inhibited its phosphorylation in
poly(I:C)-transfected RCC cells, suggesting that poly(I:C)
transfection induces ROS and subsequently leads to DNA
damage, which induces apoptosis [34,35]. In the study de-
scribed herein, we showed that poly(I:C) transfection in-
duced time-dependent increases in NOXA just after p53
activation (Figure 3c). Poly(I:C) treatment was reported
previously to induce an interaction between NOXA and
Bax, leading to mitochondrial apoptosis [36]. Puma is a
pro-apoptotic protein that facilitates apoptosis via a widevariety of stimuli in p53-dependent and -independent
manners [37]. In this study, poly(I:C) transfection slightly
decreased Puma in the RCC lines (Figure 3c).
The cytoplasmic delivery of poly(I:C) induced ROS pro-
duction in RCC cells (Figure 2a). Intriguingly, some re-
ports suggest that DNA damage induces ROS production
[15,38]. Both DNA damage and ROS production may
mutually affect this process, leading to augmentation of
apoptosis. Importantly, ROS activate caspase-2, and DNA
damage also induces cleavage of caspase-2 [39]. Caspase-2
is activated in response to DNA damage and provides an
important link between DNA damage and engagement of
the apoptotic pathway [15,38]. Additionally, ROS trigger
caspase-2 activation and induce apoptosis in a human
leukemic T cell line [40]. Based on these data, ROS trigger
DNA damage, thereby leading to activation of caspase-2.
DNA damage also induces p53 activation, resulting in
mitochondrial-mediated apoptosis.
IFN-α has been clinically applied to treat patients with
RCC [41]. IFN-α shows biological effects similar to those
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IFN-β production [22], and IFN-β mRNA expression
increased in poly(I:C)-transfected RCC cells (Figure 5a).
Therefore, we determined whether IFN-β showed an anti-
tumor effect in RCC cells. Although no apoptosis was
observed, an in vitro culture with IFN-β decreased the
number of RCC cells (Figure 5b, c), suggesting that IFN-β
shows an antitumor effect via cell-growth arrest, but not
via apoptosis in RCC cells. Note that NOXA is a type-I
IFN-response gene [36]. While both NOXA and Puma are
p53-targeted molecules, NOXA expression increased fol-
lowing poly(I:C) transfection shortly after p53 activation,
whereas Puma expression decreased, accompanying the
decreased expression of total p53 (Figure 3c). Interestingly,
p53 knockdown inhibited NOXA induction after poly(I:C)
transfection in SKRC-44 cells, but not in SKRC-1 cells
(Figure 3f). These results suggest that NOXA induction in
SKRC-44 cells after poly(I:C) transfection is highly p53-
dependent, but SKRC-1 cells are dependent on not p53
but the IFN-β response. Alternatively, induction of cell
growth arrest occurs in response to various stressors in-
cluding DNA damage [42]. This in turn allows for p53 nu-
clear translocation and activation of transcriptional targets
such as p21Waf1/Cip1, a cyclin-dependent kinase inhibitor,
to regulate cell cycle control and apoptosis [43]. Our re-
sults demonstrate that p21 expression increases transiently
in poly(I:C)-transfected SKRC-1 cells, but decreases rapidly
in poly(I:C) transfected SKRC-44 cells. G1 arrest was not
obvious in the cell cycle assay, but poly(I:C) transfection
decreased the proportion of RCC cells in the S phase
(Figure 5d). In addition, cyclinD1 and c-Myc expression de-
creased after poly(I:C) transfection (Figure 5e). Moreover,
recombinant IFN-β induced a growth arrest (Additional
file 2: Figure S2). Taken together, poly(I:C) transfection ap-
pears to induce growth arrest via IFN-β as a result of sup-
pressing the cell cycle accelerators cyclinD1 and c-Myc.
Transfection of a dsRNA poly(I:C) mimics viral infec-
tion. Cellular apoptosis after viral infection may repre-
sent an antiviral mechanism that eliminates infected
cells and prevents viral spreading. In this study, we de-
termined which innate adjuvant receptors, including
TLR3, MDA5, and RIG-I, were responsible for the ef-
fects induced in poly(I:C)-transfected RCC cells. The re-
sult showed that selective knockdown of either RIG-I,
MDA-5, or TLR3 slightly but significantly restored the
decreased cell viabilities and decreased the percentages
of apoptosis in poly(I:C)-transfected RCC cells. Add-
itionally, selective knockdown of IRF-3 significantly re-
covered the viability of poly(I:C)-transfected RCC cells
(Figure 6d, e). As IRF-3 is an adaptor molecule that is
shared by all three innate adjuvant receptors [44], this
result indicates that innate adjuvant receptors definitely
participate in the effects of poly(I:C)-transfected RCC
cells. Nevertheless, as mitigation of the effects by selectiveknockdown of IRF3 was partial, we searched for another
pathway. Besides the innate adjuvant receptors, the 2-5A
system is another system that induces apoptosis in virus-
infected cells [17]. This system is related to mitochondrial
apoptosis and IFN activates the 2–5 system [45]. In the
present study, we showed that selective knockdown of
RNaseL restored decreased cell viability and decreased the
percentage of apoptotic cells of poly(I:C)-transfected RCC
cells. This is the first report showing that the 2-5A system
participates in apoptosis of poly(I:C)-transfected human
cancer cells. Intriguingly, an RNase L mutation is associ-
ated with prostate cancer risk, suggesting that the 2-5A
system works as a tumor suppressor [46].
Conclusions
We revealed that poly(I:C) transfection induced ROS-
mediated apoptosis and IFN-β-mediated cell-growth
arrest in RCC cells. Besides caspase-8 and −9, caspase-2
was suggested to play important roles in the effects of
poly(I:C)-transfected RCC cells. We further showed that
not only the innate adjuvant receptors but also the 2-5A
system takes part in this response. Our findings unveil
new mechanisms underlying apoptosis and growth arrest
of cancer cells after poly(I:C) transfection.
Materials and methods
Cell cultures and reagents
Two human renal cell carcinoma lines (SKRC-1 and
SKRC-44) were kindly provided by Dr. K. Yoshikawa
(Aichi Medical University) and maintained in RPMI-1640
medium (Sigma-Aldrich, St. Louis, MO, USA) supple-
mented with 10% fetal bovine serum (Sigma-Aldrich) and
gentamicin (10 μg/ml) in a humidified 5% CO2 incubator
at 37°C. Low-molecular-weight poly(I:C) was purchased
from InvivoGen (San Diego, CA, USA). Recombinant hu-
man IFN-β was acquired from PeproTech (Rocky Hill, NJ,
USA). The following inhibitors were added 2 h before
poly(I:C) transfection at a dose of 20 μM to inhibit cas-
pases: the pan-caspase inhibitor z-VAD-FMK (Enzo Life
Sciences, Farmingdale, NY, USA), the caspase-8 inhibitor
z-IETD-FMK (R&D Systems, Minneapolis, MN, USA), the
caspase-9 inhibitor z-LEHD-FMK (R&D Systems), and the
caspase-2 inhibitor z-VDVAD-FMK (R&D Systems). NAC
was purchased from Sigma-Aldrich.
In vitro poly(I:C) transfection
Poly(I:C) was transfected into cancer cells using X-
tremeGENE siRNA transfection reagent (Roche Applied
Science, Mannheim, Germany), according to the manu-
facturer’s instructions.
Cell viability assay
Cell viability was analyzed using the WST-8 assay (Nacalai
Tesque, Kyoto, Japan). At the end of the incubation, 10 μl
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were incubated for an additional 3 h. Absorbance of each
well was measured at 560 nm using a microplate reader
(Beckman Coulter, Brea, CA, USA).
Microscopy
RCC cells, which were treated with or without poly(I:C),
were cultured in 6-well plates for 24 h. Morphological
changes in RCC cells were observed using an inverted
microscope (Olympus Corp., Tokyo, Japan).
Apoptosis assay
Apoptosis was examined using the Annexin V-FITC Apop-
tosis Detection Kit (BioVision, Mountain View, CA, USA)
according to the manufacturer’s instructions. In brief, cells
were stained with Annexin V-FITC and PI. Stained cells
were analyzed using FACSCalibur (BD Biosciences, San
Jose, CA, USA). Data were plotted with FCSExpress soft-
ware (De Novo Software, Los Angeles, CA, USA).
ROS measurement
Intracellular ROS were measured using carboxy-H2DCFDA
(Molecular Probes, Carlsbad, CA, USA). Treated cells were
cultured with carboxy-H2DCFDA (10 μM) for 30 min.
Thereafter, the collected cells were analyzed by flow cytom-
etry. NAC was added at a dose of 5 mM to scavenge ROS,
6 h after poly(I:C) transfection.
Mitochondrial membrane potential (ΔΨm) assay
The cells were collected 24 h after poly(I:C) transfection
in 6-well plates and incubated with MitoProbe™ DiOC2
(3) (3, 3′-diethyloxacarbicyanine iodide, Molecular Probes)
at a concentration of 8 nM for 30 min at 37°C. In some
experiments, the treated cells were stained with Annexin
V-APC (BD Pharmingen, San Jose, CA, USA), followed
by DiOC2(3). These stained cells were examined by
FACSCalibur.
DNA damage measurements
Phosphorylation of the histone H2A family member
H2A.X (γH2A.X) at Ser 139 was measured by flow cy-
tometry. Briefly, cells were fixed and permeabilized using
an IntraPrep kit (Beckman Coulter). The cells were incu-
bated with Alexa Fluor 488-conjugated anti-phospho-
γH2A.X (Ser 139) antibody (Cell Signaling Technology,
Danvers, MA, USA) and analyzed by FACSCalibur.
Immunoblotting
Cells were lysed in M-PER reagent (Pierce, Rockford, IL,
USA) with protease inhibitor cocktail (Nacalai Tesque).
Protein concentration was determined using the Coo-
massie Plus Protein Bradford Kit (Pierce). NuPAGE gels
(4–12% or 12%; Life Technologies, Carlsbad, CA, USA)
were used for protein separation, and the proteins wereimmobilized onto PVDF membranes (Life Technologies)
using the iBlot transfer system (Life Technologies). The
membranes were blocked for 30 min using TBST (Tris-
base-saline with 0.1% Tween 20) containing BlockerBSA
solution (1×) (Pierce). Incubations with primary antibodies
were performed using TBST containing BlockerBSA (1×)
overnight at 4°C. The following primary antibodies were
used: anti-phospho-γH2A.X (Ser 139) (9718), anti-
phospho-p53 (Ser 15) (9284), anti-Puma (4976), anti-Bid
(2002), anti-caspase-3 (9668), anti-caspase-2 (2224), anti-
PARP (9532), anti-cyclin D1 (2926 T), anti-p21Waf1/Cip1
(2947), anti-RIG-I (4200 T), anti-MDA5 (5321), and anti-
TLR3 (6961) (all from Cell Signaling Technology); anti-
p53 (sc-71817,), anti-NOXA (sc-30209), anti-IRF-3 (sc-
9082), anti-RNase L (sc-23955), anti-α-tubulin (sc-5286)
(all from Santa Cruz Biotechnology, Santa Cruz, CA,
USA); anti-caspase-8 (M032-3; Medical and Biological
Laboratories, Nagoya, Japan), anti-caspase-9 (M054-3;
Medical and Biological Laboratories), anti-c-Myc (1472–1;
Epitomics, Burlingame, CA, USA), and anti-β-actin
(622102) (Biolegend, San Diego, CA, USA). After washing,
the membranes were incubated for 30 min at room
temperature with alkaline phosphatase-conjugated sec-
ondary antibody. Protein bands were visualized using
CDP-star chemiluminescence and photographed with an
LAS-4000 (FujiFilm, Tokyo, Japan).
Cell cycle assay
Proliferation of cancer cells was evaluated using a BrdU/7-
aminoactinomycin D (7AAD) Flow kit (BD Pharmingen)
according to the manufacturer’s instructions. Stained sam-
ples were analyzed by FACSCalibur.
Transfection of small interfering RNA (siRNA)
Transfection of siRNA was performed using Lipofecta-
mine RNAiMAX (Life Technologies) according to the
manufacturer’s instructions. The following siRNAs were
used: TLR3 siRNA (6236; Cell Signaling Technology), con-
trol siRNA (6568; Cell Signaling Technology) caspase-2
siRNA (sc-29236), RIG-I siRNA (sc-61480), MDA5 siRNA
(sc-6101), IRF-3 siRNA (sc-35710), RNase L siRNA (sc-
45965) (all from Santa Cruz Biotechnology), and p53
siRNA (SI02655170, QIAGEN, Venlo, Netherlands). The
cancer cells were used for experiments 3 days after siRNA
transfection.
Real-time PCR
Total RNAs were extracted using the PureLink RNA Mini
Kit (Life Technologies) with DNase I treatment. cDNAs
were synthesized using random primers and the Super-
Script VILO cDNA Synthesis Kit (Life Technologies). The
synthesized first-strand cDNA was amplified using Planti-
num Tag DNA polymerase (Invitrogen) with EXPRESS
SYBR GreenER qPCR SuperMixes (Invitrogen). Real-time
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7000 Sequence Detection System. Thermal cycling in-
cluded an initial denaturation step of 2 min at 95°C,
followed by 40 cycles of 95°C for 15 sec, and 60°C for
1 min. Relative mRNA levels as compared with β-actin
were calculated. The following primers were used; IFN-α:
forward, 5′-GTG AGG AAA TAC TTC CAA AGA ATC
AC-3′; and reverse, 5′-TCT CAT GAT TTC TGC TCT
GAC AA-3′; IFN-β: forward, 5′-AGC TGA AGC AGT
TCA GAA G-3′; and reverse, 5′-AGT CTC ATT CCA
GCC AGT GC-3′; β-actin: forward, 5′-GCG AGA AGA
TGA CCC AGA TC-3′; and reverse, 5′-CCA GTG GTA
CGG CCA GAG G-3′.
RNA degradation assay
After RNA extraction, 4 μg total RNA from each reac-
tion was denatured and analyzed by electrophoresis in
1% agarose-formaldehyde gels. Ethidium bromide and
UV light revealed the location of the RNA bands within
the gels.
Statistical analyses
Data were evaluated statistically using the unpaired two-
tailed Student’s t-test. A P-value < 0.05 was considered
significant.
Additional files
Additional file 1: Figure S1. Effects of caspase-2 knockdown on
apoptosis in poly(I:C) transfected RCC cells. Both cell lines, which were
pre-transfected with control or caspase-2 siRNA 3 days prior, were
transfected additionally with poly(I:C) (SKRC-1, 1,000 ng/ml; SKRC-44,
500 ng/ml). Cells were then stained with FITC-conjugated Annexin V
and PI and analyzed by flow cytometry after 24 h. Numbers represent the
percentages for each subset. pIC-TF, poly(I:C) transfection.
Additional file 2: Figure S2. Effects of IFN-β on RCC growth. Both cell
lines were cultured with or without IFN-β (1,000 U/ml) for 48 h. Cells
were then cultured with BrdU (10 μM) during the last 90 min for SKRC-1
and 6 h for SKRC-44. After staining with FITC-conjugated anti-BrdU and
7-AAD, cells were analyzed by flow cytometry. Numbers represent the
percentages for each cell cycle phase.
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